1 hr ago
FDA Recalls Thyroid Pills Over Superpotency, Urges Patient Caution
Some thyroid pills have been recalled because they may be stronger than intended.
The affected medicine has lot number 504950.
Patients should look for this number on their medicine.
They should not assume that every thyroid pill is part of the recall.
Anyone with the affected lot should contact a doctor or healthcare provider.
A doctor may provide a replacement prescription if needed.
Patients should not stop taking the medicine on their own.
Changing thyroid medicine suddenly can cause problems because it needs to be carefully managed.
The FDA and manufacturer recalled thyroid pills associated with lot number 504950.
Patients should check their medicine’s lot number rather than assume all thyroid tablets are affected.
People with lot 504950 should contact their doctor or healthcare provider.
Doctors may recommend a replacement prescription if appropriate.
Patients should not abruptly stop or change thyroid medication without medical advice.
- Who
- The Food and Drug Administration, the manufacturer, and patients taking the thyroid medicine.
- What
- A recall was issued for thyroid pills associated with lot number 504950 because of possible superpotency.
- Where
- When
- Why
- The pills may be more potent than intended, requiring patients to seek medical guidance about continued treatment or replacement medication.
Key facts
- Recall status
- Thyroid pills associated with lot 504950 have been recalled.
- Issue
- The recall involves possible superpotency.
- Agency
- The Food and Drug Administration is involved in the recall guidance.
- Affected lot
- 504950
- Patient action
- Check the lot number and contact a doctor or healthcare provider if it matches.
- Medication guidance
- Do not stop or change the medication abruptly without medical advice.
Sources
Related news
FDA Upgrades Recall of Potentially Superpotent Thyroid Tablets
Bombay High Court Rebukes FDA, Cipla Licence Order Withdrawn
Pfizer Backs Karnataka Probe, Says Patient Safety Comes First
Abhayrab Potency Test Raises Questions Over Seized Vaccine Vials
Firstpost Story Sparks India-Netherlands Effort for Affordable Tiratricol
Delhi Health Minister Orders Full Essential Medicine Availability
FDA Approves SELUTION SLR Balloon for In-Stent Restenosis
After Caffeine Overdose, 25-Year-Old Man Dies, Inquest Finds
FDA Suspends BigBasket Outlet Licence Over Food Safety Violations
